Improvement in Distress Tolerance as a Mechanism of Symptom Reduction During Intensive Exposure and Response Prevention–Based Treatment for OCD
Behavior Therapy · 2025-01 · 56 (1) · 43-56
DOI: 10.1016/j.beth.2023.12.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Behavior Therapy, 2025-01. Verfasst von Donald A Godfrey und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Utah. Electronic address: Andy.Godfrey@hsc.utah.edu. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, Implosive Therapy, Anxiety, Depression. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Utah. Electronic address: Andy.Godfrey@hsc.utah.edu.
- Baylor University.
- OCD Institute of Texas.
- Barnard College.
- McLean Hospital, Harvard Medical School, and University of Bergen.
Zitieren
APA
Godfrey, D. A., Heinrich, A., McIngvale, E., Sy, J., Wheaton, M. G., & Björgvinsson, T. (2025). Improvement in Distress Tolerance as a Mechanism of Symptom Reduction During Intensive Exposure and Response Prevention–Based Treatment for OCD. Behavior Therapy, 56(1), 43-56. https://doi.org/10.1016/j.beth.2023.12.006
Vancouver
Godfrey DA, Heinrich A, McIngvale E, Sy J, Wheaton MG, Björgvinsson T. Improvement in Distress Tolerance as a Mechanism of Symptom Reduction During Intensive Exposure and Response Prevention–Based Treatment for OCD. Behavior Therapy. 2025;56(1):43-56. doi:10.1016/j.beth.2023.12.006
BibTeX
@article{Godfrey2025,
author = {Godfrey, Donald A and Heinrich, Allison and McIngvale, Elizabeth and Sy, Jennifer and Wheaton, Michael G and Björgvinsson, Thröstur},
title = {Improvement in Distress Tolerance as a Mechanism of Symptom Reduction During Intensive Exposure and Response Prevention–Based Treatment for OCD},
journal = {Behavior Therapy},
year = {2025},
volume = {56},
number = {1},
pages = {43--56},
doi = {10.1016/j.beth.2023.12.006}
}
EUVIMED